Mesco Pharmaceuticals Financials

NSE: MESCOPHARM | BSE: 500274

₹4.54

₹0.21 (4.85%)

As on 10-Jan-2022IST

Market cap

₹9 Cr

Revenue (TTM)

₹0 Cr

P/E Ratio

P/B Ratio

-0.9

Div. Yield

0 %

Income Statement (₹ Cr)	TTM	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Operating Revenue	--	--	--	--	--	--
Total Income	--	--	--	--	--	--
Total Expenditure	0.01	0.00	0.10	0.41	0.09	0.26
EBITDA	-0.01	0.00	-0.10	-0.41	-0.09	-0.26
Depreciation	--	--	--	--	--	--
EBIT	-0.01	0.00	-0.10	-0.41	-0.09	-0.26
Interest	--	0.00	0.00	--	0.00	--
Other Income	--	--	--	--	--	--
Exceptional Items	--	--	--	--	--	--
Profit before Tax	-0.01	0.00	-0.10	-0.41	-0.09	-0.26
Provision for Tax	--	--	--	--	--	0.00
Profit after Tax	-0.01	0.00	-0.10	-0.41	-0.09	-0.26

Liabilities (₹ Cr)	TTM	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Shareholder's Funds	-11.02	-11.02	-11.01	-10.91	-10.51	-10.42
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	11.18	11.18	11.22	11.14	10.75	10.66
Current Liabilities	0.02	0.02	0.01	0.02	0.01	0.01
Total Liabilities	0.18	0.18	0.22	0.25	0.25	0.25

Assets (₹ Cr)	TTM	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Non-Current Assets	0.18	0.18	0.18	0.21	0.21	0.21
Current Assets	0.00	0.00	0.04	0.04	0.04	0.04
Total Assets	0.18	0.18	0.22	0.25	0.25	0.25
Total Debt*	--	11.18	11.22	11.14	10.75	10.66
Net Current Assets	-0.02	-0.01	0.02	0.02	0.03	0.03
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	TTM	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Cash From Operating Activities	--	0.00	-0.08	-0.39	-0.09	-0.26
Cash Flow from Investing Activities	--	--	--	--	--	--
Cash from Financing Activities	--	-0.03	0.08	0.39	0.09	0.26
Net Cash Inflow / Outflow	--	-0.04	0.00	--	0.00	--

Financials Ratios	TTM	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Adjusted EPS (₹)	0.00	0.00	-0.05	-0.21	-0.04	-0.13
Cash EPS (₹)	--	0.00	-0.05	-0.21	-0.04	-0.13
Adjusted Book Value (₹)	--	-5.58	-5.58	-5.53	-5.32	-5.28
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	0.00	-0.04	-0.20	-0.04	-0.13
Free Cash Flow per Share (₹)	--	0.00	-0.05	-0.20	-0.04	-0.13

Profitability Ratios	TTM	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
ROCE (%)	--	-2.08	-45.82	-176.12	-36.29	-108.57
ROE (%)	--	--	--	--	--	--
ROA (%)	-2.49	-1.99	-42.08	-165.20	-35.22	-104.48
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-25.00	96.07	76.01	-369.24	66.15	-4,126.06
Net Profit Growth (%)	-25.00	95.93	76.01	-369.16	66.27	-1,344.04
EPS Growth (%)	-25.00	95.98	76.01	-369.16	66.27	-1,349.54
Book Value Growth (%)	--	-0.04	-0.90	-3.90	-0.84	-2.55

Valuation Ratios	TTM	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Price / Earnings	--	--	--	--	--	--
Price / Book Value	-0.88	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-4,081.20	-7,999.21	-314.50	-75.25	-348.60	-117.66
Close Price (₹)	--	--	--	--	--	--
High Price (₹)	--	--	--	--	--	--
Low Price (₹)	--	--	--	--	--	--
Market Cap (₹ Cr)	9.23	--	--	--	--	--

Solvency Ratios	TTM	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Debt to Equity	-1.01	-1.02	-1.02	-1.02	-1.02	-1.02
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	0.17	0.18	2.69	1.68	5.54	5.19
Quick Ratio	0.17	0.18	2.69	1.68	5.54	5.19
Interest Coverage	--	-28.38	-3,332.29	--	-5,822.27	--

Operating Efficiency Ratios	TTM	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement (₹ Cr)